IL6 and myeloid sarcoma: Moreover, selective inhibition of STAT3 is particularly important in an inflammatory environment such as MS lesions where multiple cytokines are present, including TGF-β and IL-6, since STAT3 is a fate decision point of Th17 and Tregs.